GPN-00068
N/A
Report date: 2023/03/30 10:11:54
NME
Base Information
Drug NameGPN-00068
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGrand Pharmaceutical (China) Co LtdBroad Pharmaceutical Technology (Wuhan) Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesBroad Pharmaceutical Technology (Wuhan) Co LtdShanghai Xudong Haipu Pharmaceutical Co LtdGrand Pharmaceutical (China) Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A